Hope is on the horizon for needle-phobic patients as Griffith University researchers have created a new influenza vaccine ...

a needle-free nasal spray influenza vaccine for self-administration. "EMA CHMP recommends AstraZeneca’s Fasenra to treat EGPA ...

Gentle nasal spray vaccines against COVID, the flu and RSV are coming. They may work better than shots in the arm ...

A needle-free injection will soon be available to thousands of diabetics. A British company has designed a £120 gadget that could free diabetics from the daily trauma of painful injections.

AstraZeneca bioPharmaceuticals business unit executive vice-president Ruud Dobber stated: “Today’s approval of Fasenra, with its convenient, single-monthly injection, is a positive step ...

The European Commission has approved the Committee for Medicinal Products for Human Use (CHMP) recommendation to change the terms of marketing authorization for Fasenra (benralizumab). It can now ...

AstraZeneca’s Fasenra (benralizumab) injected drug cuts the size of nasal polyps and nasal blockage in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). The company announced top ...

Today’s approval of Fasenra, with its convenient, single-monthly injection is a positive step forward for patients with EGPA. Fasenra has been a well-established treatment for many years in thousands ...

PITTSBURGH (KDKA) — Pittsburgh's needle exchange program is running again after the city suspended it last year after collection problems. Many of the homeless encampments have become dens of ...

AstraZeneca’s (AZN) Fasenra has been approved in the European Union, EU, as an add-on treatment for adult patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis ...

Report Ocean has published a new report on the Saudi Arabia Needle-free Injection System Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities.